17-7495924-CCTTT-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BA1
The NM_000937.5(POLR2A):c.94-8_94-5del variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0398 in 1,613,604 control chromosomes in the GnomAD database, including 1,788 homozygotes. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.059 ( 410 hom., cov: 31)
Exomes 𝑓: 0.038 ( 1378 hom. )
Consequence
POLR2A
NM_000937.5 splice_polypyrimidine_tract, intron
NM_000937.5 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.417
Genes affected
POLR2A (HGNC:9187): (RNA polymerase II subunit A) This gene encodes the largest subunit of RNA polymerase II, the polymerase responsible for synthesizing messenger RNA in eukaryotes. The product of this gene contains a carboxy terminal domain composed of heptapeptide repeats that are essential for polymerase activity. These repeats contain serine and threonine residues that are phosphorylated in actively transcribing RNA polymerase. In addition, this subunit, in combination with several other polymerase subunits, forms the DNA binding domain of the polymerase, a groove in which the DNA template is transcribed into RNA. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 17-7495924-CCTTT-C is Benign according to our data. Variant chr17-7495924-CCTTT-C is described in ClinVar as [Benign]. Clinvar id is 3056317.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.122 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLR2A | NM_000937.5 | c.94-8_94-5del | splice_polypyrimidine_tract_variant, intron_variant | ENST00000643490.2 | NP_000928.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POLR2A | ENST00000674977.2 | c.94-8_94-5del | splice_polypyrimidine_tract_variant, intron_variant | ENSP00000502190 | P1 | |||||
POLR2A | ENST00000572844.1 | n.239-8_239-5del | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 1 | ||||||
POLR2A | ENST00000617998.6 | n.493-8_493-5del | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.0591 AC: 8988AN: 152102Hom.: 396 Cov.: 31
GnomAD3 genomes
AF:
AC:
8988
AN:
152102
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0361 AC: 9082AN: 251270Hom.: 276 AF XY: 0.0341 AC XY: 4628AN XY: 135836
GnomAD3 exomes
AF:
AC:
9082
AN:
251270
Hom.:
AF XY:
AC XY:
4628
AN XY:
135836
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0378 AC: 55244AN: 1461384Hom.: 1378 AF XY: 0.0366 AC XY: 26633AN XY: 727030
GnomAD4 exome
AF:
AC:
55244
AN:
1461384
Hom.:
AF XY:
AC XY:
26633
AN XY:
727030
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0593 AC: 9028AN: 152220Hom.: 410 Cov.: 31 AF XY: 0.0574 AC XY: 4270AN XY: 74424
GnomAD4 genome
AF:
AC:
9028
AN:
152220
Hom.:
Cov.:
31
AF XY:
AC XY:
4270
AN XY:
74424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
155
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
POLR2A-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 05, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at